Evidence map›Paper›PMID 18461013›Full record

ArticleSexually transmitted diseases2008

Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting.

Diane R Blake, Nancy Maldeis, Mathilda R Barnes, Andrew Hardick, Thomas C Quinn, Charlotte A Gaydos

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Sexually transmitted diseases, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Accuracy of self-collection versus cervical sampling for the molecular diagnosis ofRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Article
  8. Article
  9. Cost-Effectiveness Analysis of Michigan's School-Wide Sexually Transmitted Disease Screening Program in Four Detroit High Schools.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Self-taken vaginal swabs versus clinician-taken for detection of candida and bacterial vaginosis: a case-control study in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2017
    Article
  14. Article
  15. Journal of clinical outcomes management : JCOM · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Diane R BlakeDepartment of Pediatrics, Division of Adolescent Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA. diane.blake@umassmed.edu
Nancy Maldeis
Mathilda R Barnes
Andrew Hardick
Thomas C Quinn
Charlotte A Gaydos
Office of Infectious Diseases · USNational Institute of Allergy and Infectious Diseases · USUniversity of Massachusetts Chan Medical School · US

Funding

HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
Immunopathogenesis Of Chlamydia trachomatis InfectionZIAAI000358 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI QUINN, THOMAS · 2009 to 2022
$7.0M
INTERNATIONAL STUDIES ON THE ACQUIRED IMMUNODEFICIENCY SYNDROMEZ01AI000361 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI QUINN, THOMAS · 1985 to 2008
$3.1M
IMMUNOPATHOGENESIS OF CHLAMYDIA TRACHOMATIS INFECTIONSZ01AI000358 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI QUINN, THOMAS · 1985 to 2008
$745k
Intramural NIH HHS Z01 AI000358NIAID NIH HHS U01 AI068613NIAID NIH HHS U01-AI-068613
6 · The paper itself

Abstract

backgroundWe evaluated the cost-effectiveness of Chlamydia screening strategies that use different methods of specimen collection: cervical swabs, urines, and self-obtained vaginal swabs.

methodsA decision analysis was modeled for a hypothetical cohort of 10,000 per year of women attending sexually transmitted disease (STD) clinics. Incremental cost-effectiveness of 4 screening strategies were compared: 1) Endocervical DNA probe test (PACE2, Gen-Probe), 2) Endocervical AC2 (Aptima Combo 2, Gen-Probe), 3) Self-Obtained Vaginal AC2, and 4) Urine AC2. Sensitivities of the vaginal, urine, and cervical AC2 tests were derived from 324 women attending STD clinics. The primary outcome was cases of pelvic inflammatory disease prevented. The model incorporated programmatic screening and treatment costs and medical cost savings from sequelae prevented.

resultsChlamydia prevalence in the sampled population was 11.1%. Sensitivities of vaginal, urine, and cervical AC2 were 97.2%, 91.7%, and 91.7%, respectively. The sensitivity of the DNA probe was derived from the literature and estimated at 68.8%. The self-obtained vaginal AC2 strategy was the least expensive and the most cost-effective, preventing 17 more cases of pelvic inflammatory disease than the next least expensive strategy.

conclusionsUse of a vaginal swab to detect Chlamydia in this STD clinic population was cost-saving and cost-effective.

Indexed as

AdolescentAdultAmbulatory Care FacilitiesChlamydia InfectionsChlamydia trachomatisCohort StudiesCost-Benefit AnalysisDNA, BacterialFemaleHumansMarylandMass ScreeningPelvic Inflammatory DiseasePredictive Value of TestsPrevalenceSelf AdministrationDNA, Bacterial

Identifiers

PMID18461013
PMCPMC2711851
OpenAlexW1971587208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.